AFA responds to approval of Alzheimer’s Drug by FDA Advisory Committee

Published: Jun. 12, 2024 at 12:23 PM AKDTFAIRBANKS, Alaska - The U.S. Food and Drug Administration Advisory Committee, has approved the Alzheimer’s drug, donanemab. of the clinical trials reported in July of 2023, the drug significantly slowed the cognitive and functional decline in those living with early Alzheimer’s disease.to the FDA Advisory Committee’s approval of donanemab by saying:

“We are encouraged by the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee’s unanimous approval of donanemab and are optimistic that, if fully approved by the FDA, it will make a positive difference in the lives of individuals living with Alzheimer’s disease and their family caregivers. The FDA should keep the review process moving forward and set a date for final determination.

“This is a positive sign of continuing progress, but we must keep moving forward toward the finish line, which is a cure for Alzheimer’s disease. Federal policymakers must continue increasing investments in Alzheimer’s disease research and support services for caregivers.” Donanemab is not a cure for Alzheimer’s and all other dementia, but it has shown to slow the progression of the disease. For more information about the newly approved drug please visit their

Source: Healthcare Press (healthcarepress.net)

Caregivers Alzheimer’S Foundation Of America FDA Donanemab The U.S. Food And Drug Administration Dementia

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Hot flashes treatment: FDA approves new drug for night sweatsLinda Carroll is a regular health contributor to NBC News. She is coauthor of 'The Concussion Crisis: Anatomy of a Silent Epidemic' and 'Out of the Clouds: The Unlikely Horseman and the Unwanted Colt Who Conquered the Sport of Kings.'
Source: NBCNews - 🏆 10. / 86 Read more »

Drug advertisements will look different as new FDA rule takes effect MondayA new FDA rule takes effect Monday requiring radio and television advertisements for prescription drugs to clearly explain side effects.
Source: dcexaminer - 🏆 6. / 94 Read more »

FDA Approves New Drug for Deadly Lung CancerThe U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.
Source: MedicineNet - 🏆 575. / 51 Read more »

Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. The Food and Drug Administration posted its review of the drug on Friday, raising questions about its effectiveness and potential risks, including heart problems.
Source: AP - 🏆 728. / 51 Read more »

Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD.
Source: wjxt4 - 🏆 246. / 63 Read more »

Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD.
Source: ksatnews - 🏆 442. / 53 Read more »